-
CPHI Korea 2025 Aug 26-28, Seoul, South Korea
Symeres will be attending CPHI Korea 2025, a leading pharmaceutical event in the Asia-Pacific region that highlights innovation in drug development, APIs, and manufacturing with strategic partnerships. We look forward to connecting with partners, clients, and fellow innovators!
-
EFMC-ASMC 2025 Aug 31 – Sept 4, Porto, Portugal
Symeres is excited to attend EFMC-ASMC 2025! We look forward to connecting with global leaders in synthetic and medicinal chemistry to share insights and drive innovation in drug discovery. See you there!
-
DMDG Open Meeting 2025 Sep 2-4th, York, UK
We are happy to share that Symeres will be attending DMDG 2025, the UK’s leading conference for drug metabolism and pharmacokinetics, bringing together experts in ADME, bioanalysis, and predictive science with our daughter company, Admescope. We look forward to connecting with peers and partners to share how our integrated drug discovery and ADME-Tox services support early-stage development.
-
Chem Outsourcing 2025 Sep 2-5, Parsippany, NJ USA
Symeres will be present at ChemOutsourcing 2025, the largest U.S.-based API and pharmaceutical ingredients show with 700+ industry professionals in attendance. The event focuses on the entire API development supply chain, including raw materials, drug discovery, process development, and commercial manufacturing.
Symeres looks forward to connecting with partners, clients, and fellow innovators to discuss how we can support your drug discovery and development needs
-
14th International ISSX Meeting Sep 21-24, Chicago, IL
We are excited to announce that Symeres will be attending the 14th International ISSX Meeting, a global forum for experts in xenobiotic metabolism, pharmacokinetics, and drug disposition. We look forward to connecting with scientists and partners to discuss how our integrated drug discovery and ADME-Tox services can advance your development programs with our daughter company, Admescope.
-
Discovery on Target 2025 Sep 22-25, Boston, MA
Symeres will be attending Discovery on Target (DoT) 2025, the industry’s leading event focused on novel drug targets and early discovery technologies. We look forward to engaging with innovators and collaborators to share how our integrated drug discovery and early development services can accelerate your path to the clinic.
-
Oxford Global Discovery and Development US 2025 Oct 2-3, San Diego, CA USA
Symeres is pleased to participate in Oxford Global Discovery and Development US 2025, a leading conference uniting top experts in drug discovery and early development from across the pharma industry. We look forward to meeting partners and peers to showcase how our integrated drug discovery, early development, and API services can support your R&D goals.
-
CPHI Worldwide 2025 Oct 28-30, Frankfurt, Germany
Join Symeres at CPHI Worldwide, where pharmaceutical professionals converge to drive innovation. We’re excited to share how our full-spectrum drug discovery and API capabilities can help advance your projects efficiently.
-
BOS Manchester 2025 Nov 25-26, Manchester, UK
We’re proud to be part of BOS Manchester 2025, bringing together industry experts focused on advancing biopharmaceutical development. Symeres is eager to showcase our end-to-end drug discovery and development capabilities.
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.